Li J T, Li Y L, Chen H Z, Sun B
Department of Pancreatic and Biliary Surgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Zhonghua Wai Ke Za Zhi. 2018 Nov 1;56(11):873-876. doi: 10.3760/cma.j.issn.0529-5815.2018.11.018.
Pancreatic fistula is a common and serious complication after pancreatic surgery. Pancreatic fistula, intra-abdominal infection and hemorrhage are known as the " lethal triad" after pancreatic surgery, which seriously affect the curative efficacy of operation. Although the incidence of pancreatic fistula has not been significantly reduced, there have been a large number of studies on the risk factors of pancreatic fistula and the means of prevention and therapy, which try to minimize the harm of pancreatic fistula. In this article we review the recent development of the latest definition, high risk factors and treatment of postoperative pancreatic fistula according to relevant literatures at home and abroad, aiming at summarizing the research advances on the therapy of pancreatic fistula after pancreatic surgery.
胰瘘是胰腺手术后常见且严重的并发症。胰瘘、腹腔内感染和出血被称为胰腺手术后的“致命三联征”,严重影响手术疗效。尽管胰瘘的发生率尚未显著降低,但针对胰瘘的危险因素及防治手段已有大量研究,旨在将胰瘘的危害降至最低。本文根据国内外相关文献,对术后胰瘘的最新定义、高危因素及治疗的研究进展进行综述,旨在总结胰腺手术后胰瘘治疗方面的研究进展。